Why Doing the Right Things Matters More Than Doing All the Things
September 2, 2026

A Functional Medicine Perspective from Peak Health Institute
GLP-1 medications such as semaglutide and tirzepatide have become some of the most talked about therapies in modern metabolic medicine. Originally developed to treat type 2 diabetes, these peptides are now widely used to support weight loss and metabolic health.
While the results can be powerful, patients often worry about side effects. The good news is that
when GLP-1 therapies are used thoughtfully, at appropriate doses, and alongside strong
lifestyle foundations, many of these side effects can be minimized.
At Peak Health Institute, our philosophy is simple: use the lowest effective dose, support the
body’s physiology, and prioritize long-term metabolic health rather than rapid weight loss.
GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces after eating.
It helps regulate several important metabolic processes, including:
Because these medications make people feel full sooner and decrease appetite, they often lead to significant weight loss and metabolic improvements.

One of the most exciting developments in GLP-1 research is the growing evidence that these medications may also support cardiovascular health and metabolic resilience.
Additional research suggests GLP-1 therapies may also:
This is why GLP-1 medications are increasingly being studied not only as weight-loss tools but also as metabolic and cardiovascular therapies.
Like any therapy that alters metabolism, GLP-1 peptides can cause side effects, particularly when doses are increased too quickly.
The most common side effects include:
These symptoms occur primarily because GLP-1 slows stomach emptying and alters digestive signaling.
Across clinical trials, gastrointestinal symptoms are the most frequently reported adverse effects.
The encouraging part is that these symptoms are often temporary and dose-dependent, meaning they tend to improve when dosing is managed appropriately.
A growing number of functional and longevity-focused practices are exploring microdosing approaches to GLP-1 therapy.
Instead of rapidly escalating to high doses, microdosing focuses on:
This approach may help:
The goal is not simply aggressive appetite suppression. Instead, the goal is metabolic support while maintaining healthy nutrition and lifestyle habits.

At Peak Health Institute, we emphasize several foundational strategies to help patients tolerate GLP-1 therapy well.
One of the biggest risks when appetite decreases is losing muscle mass instead of fat.
Patients should aim to consume adequate protein daily to support:
Protein also helps prevent fatigue and nutrients deficiencies that can occur when food intake drops too quickly.
Reduced appetite often leads people to unintentionally drink less water. Hydration is essential for:
Electrolytes and mineral support can also be helpful, particularly for active individuals.
Many side effects occur when doses are increased too quickly.
Using the lowest effective dose allows the body to adapt gradually while still benefiting from improved metabolic signaling.
In many cases, patients do not need the highest doses marketed for weight loss.
Strength training and regular movement are essential when using GLP-1 therapies.
Exercise helps:
Without resistance training, some patients may lose muscle during weight loss.
Even though appetite may be lower, the food that is eaten should still be high quality and nutrient dense.
A well-structured diet should emphasize:
This supports metabolic health and prevents nutritional deficiencies.
GLP-1 medications can be powerful tools when used correctly. But they are most effective when
combined with strong lifestyle foundations.
Weight loss achieved through:
is far more sustainable than weight loss driven purely by appetite suppression.

GLP-1 therapies have demonstrated impressive benefits for metabolic health, including weight
loss and reductions in cardiovascular risk. However, side effects effects can occur — particularly when
dosing is too aggressive or lifestyle support is missing.
By focusing on microdosing strategies, high protein intake, proper hydration, exercise, and
nutrient-dense nutrition, many patients can experience the benefits of GLP-1 therapy while
minimizing unwanted symptoms.
At Peak Health Institute, we take a personalized approach to metabolic health and weight
management. Our team focuses on supporting the whole system — not just prescribing
medication.
If you’re curious whether GLP-1 therapy or microdosing strategies may be appropriate for you, we invite you to schedule a consultation with one of our providers to discuss your goals and create a personalized plan.
Sign Up for our Newsletter for weekly updates
To your best health,
Katie